Please login to the form below

Not currently logged in
Email:
Password:

Natco Pharma

This page shows the latest Natco Pharma news and features for those working in and with pharma, biotech and healthcare.

Teva faces early rival to longer-acting Copaxone in US

Teva faces early rival to longer-acting Copaxone in US

the importance Copaxone (glatiramer acetate) has to the Israeli pharma group’s finances. ... The approval and launch is also big news for Indian company Natco Pharma, which partnered with Mylan on developing the generic and will share profits on sales.

Latest news

  • India turns down patent on Gilead's Sovaldi India turns down patent on Gilead's Sovaldi

    Last year, Sovaldi's Indian intellectual property (IP) also faced a "pre-grant" objection from domestic pharma company Natco as well as the New York-based Initiative for Medicines, Access &Knowledge ... The Indian ruling suggests other drugmakers like

  • BMS says it defends Sprycel patent in India BMS says it defends Sprycel patent in India

    BDR had been trying to secure a compulsory license to overturn BMS' 2010 Indian patent on Sprycel on the grounds of public need, a strategy which allowed Natco Pharma to start ... Towards the end of last year court documents suggested Natco was no longer

  • Bayer fails to overturn Nexavar compulsory licence in India Bayer fails to overturn Nexavar compulsory licence in India

    Natco Pharma allowed to sell cut-price version of cancer drug. Bayer's first attempt at overturning a compulsory license in India for its cancer drug Nexavar was knocked back yesterday ... The Intellectual Property Appellate Board (IPAB) upheld the

  • India could hit Roche and BMS with compulsory licences India could hit Roche and BMS with compulsory licences

    The first compulsory licence in India was introduced last year for Bayer's liver cancer drug Nexevar (sorefinib), allowing Natco Pharma to sell a copy of the treatment that was 95 ... It is a very good move and will not just benefit Indians but possibly

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics